+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Occupational hypersensitivity pneumonitis: an EAACI position paper

Occupational hypersensitivity pneumonitis: an EAACI position paper

Allergy 71(6): 765-779

The aim of this document was to provide a critical review of the current knowledge on hypersensitivity pneumonitis caused by the occupational environment and to propose practical guidance for the diagnosis and management of this condition. Occupational hypersensitivity pneumonitis (OHP) is an immunologic lung disease resulting from lymphocytic and frequently granulomatous inflammation of the peripheral airways, alveoli, and surrounding interstitial tissue which develops as the result of a non-IgE-mediated allergic reaction to a variety of organic materials or low molecular weight agents that are present in the workplace. The offending agents can be classified into six broad categories that include bacteria, fungi, animal proteins, plant proteins, low molecular weight chemicals, and metals. The diagnosis of OHP requires a multidisciplinary approach and relies on a combination of diagnostic tests to ascertain the work relatedness of the disease. Both the clinical and the occupational history are keys to the diagnosis and often will lead to the initial suspicion. Diagnostic criteria adapted to OHP are proposed. The cornerstone of treatment is early removal from exposure to the eliciting antigen, although the disease may show an adverse outcome even after avoidance of exposure to the causal agent.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058448059

Download citation: RISBibTeXText

PMID: 26913451

DOI: 10.1111/all.12866

Related references

Monitoring of occupational and environmental aeroallergens-- EAACI Position Paper. Concerted action of the EAACI IG Occupational Allergy and Aerobiology & Air Pollution. Allergy 69(10): 1280-1299, 2015

EAACI position paper on occupational rhinitis. Respiratory Research 10: 16-16, 2009

Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy 70(7): 755-763, 2016

EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies. Allergy 68(5): 580-584, 2013

Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group. Allergy 68(7): 844-852, 2013

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71(8): 1103-1134, 2016

Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy 71(11): 1533-1539, 2016

EAACI Position Paper on assessment of cough in the workplace. Allergy 69(3): 292-304, 2014

AAAAI support of the EAACI Position Paper on IgG4. Journal of Allergy and Clinical Immunology 125(6): 1410-1410, 2010

EAACI position paper: irritant-induced asthma. Allergy 69(9): 1141-1153, 2015

Diagnostic tools in Rhinology EAACI position paper. Clinical and Translational Allergy 1(1): 2-2, 2011

Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clinical and Translational Allergy 2(1): 21-21, 2012

Global classification and coding of hypersensitivity diseases - An EAACI - WAO survey, strategic paper and review. Allergy 69(5): 559-570, 2014

The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy 51(10): 666-675, 1996

Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy 70(8): 897-909, 2016